Results 1 to 10 of about 27,194 (296)

A prospective, single-centre study of the feasibility of the use of augmented reality for improving the safety and traceability of injectable investigational cancer drug compounding [PDF]

Heliyon
The compounding of injectable cancer drugs for clinical trials often requires specific procedures, with limited access to the starting materials and especially the active compound.
Arthur Lecoutre, Michele Vasseur, Justin Courtin, Slim Hammadi, Bertrand Decaudin, Odou Pascal   +5 more
doaj   +3 more sources

Drug compounding for veterinary patients [PDF]

AAPS Journal, 2005
Drugs have been compounded for veterinary practice for many years because it has been necessary in the course of routine practice. However, regulations and compliance policy guidelines (CPGs) should be recognized. A new CPG issued in July 2003 listed the current Food and Drug Administration (FDA) limitations on compounding for veterinary medicine.
Mark G Papich, Papich Mark G
exaly   +3 more sources

Improving the Efficiency of the Intravenous Medicine Preparation Pathway With an Intravenous Workflow Software Solution in Full-Capacity Pharmacy Units at Watford General Hospital: Observational Study and Economic Analysis [PDF]

JMIR Human Factors
BackgroundThe existing intravenous systemic anticancer therapy (SACT) pathway in pharmacies is operationally inefficient. Manual, paper-based workflows render the system prone to human error, and the need for time-consuming manual
Bethany Umpleby, Nick Hex, Teresa Martins, Husanain Soori   +3 more
doaj   +2 more sources

Veterinary Compounding: Regulation, Challenges, and Resources

Pharmaceutics, 2017
The spectrum of therapeutic need in veterinary medicine is large, and the availability of approved drug products for all veterinary species and indications is relatively small.
Gigi Davidson
doaj   +2 more sources

RETRACTED: Extemporaneous Compounding: Selective Pharmacists with Separate Skill

INNOVATIONS in Pharmacy, 2019
This article has been retracted: please see INNOVATIONS in pharmacy retraction policy (https://pubs.lib.umn.edu/index.php/innovations/policies). This article has been retracted by the Editor and Publisher due to the inappropriate use of previously ...
AK Mohiuddin
doaj   +3 more sources

Three-Dimensional Printing of PVA Capsular Devices for Applications in Compounding Pharmacy: Effect of Design Parameters on Pharmaceutical Performance

Pharmaceutics
The creation of products with personalized or innovative features in the pharmaceutical sector by using innovative technologies such as three-dimensional (3D) printing is particularly noteworthy, especially in the realm of compounding pharmacies. In this
Juan Francisco Peña, Ivana Cotabarren, Loreana Gallo   +2 more
doaj   +2 more sources

A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging

Therapeutic Advances in Drug Safety
Hospital pharmacies play a unique role in healthcare by regularly compounding drug products (DPs) in response to hospital demands and practices, for example, drug shortages, to cater to frail and vulnerable patients with infectious, chronic or nutrition ...
William Bello, Julian Pezzatti, Camille Stampfli, Laurent Carrez, Serge Rudaz, Farshid Sadeghipour   +5 more
doaj   +2 more sources

Evaluation of Pharmaceutical Compounding Training in the Australian Undergraduate Pharmacy Curricula [PDF]

Pharmacy, 2020
Introduction: In recent decades the role of the Australian community pharmacist has evolved to focus primarily on pharmaceutical care provision. Despite this, compounding remains an important product service offered by pharmacists.
Sam Kosari, Vera H. Buss, Gregory M. Peterson, Kwang Choon Yee, Mark Naunton, Mary Bushell, Leroy Chiu, Jackson Thomas   +7 more
doaj   +3 more sources

Review of BRICS regulatory practices in the field of drugs compounding

Фармация и фармакология (Пятигорск)
In the formation of a common market within the framework of interstate associations (Unions), the goal of improving the health of the member states population can be achieved, among other things, by providing an unimpeded access to safe, effective and ...
D. S. Yurochkin, D. D. Mamedov, S. E. Erdni-Garyaev, A. V. Yarutkin, V. L. Bagirova, P. S. Guryanov, O. Loudiyi, W. Li   +7 more
doaj   +3 more sources

Adverse drug events from paediatric use of extemporaneously compounded medicines in community pharmacy settings: a scoping review [PDF]

BMJ Paediatrics Open
Background Extemporaneously compounded medicines are widely used in paediatric patients. However, the associated extent and nature of adverse drug events from these products remained unclear.Aims To summarise the characteristics of adverse drug events ...
Rose Cairns, Nicholas A Buckley, Jasmine Lee, Jiawen Li   +3 more
doaj   +2 more sources